Suboxone Tooth Decay Lawsuit

August 1st, 2025: August 2025 JPML Update

Between July and August, the Suboxone tooth decay MDL saw a slight dip in active cases, decreasing from 890 to 889.

Plaintiffs continue to allege that the drug’s sublingual film formulation, used in opioid addiction treatment, caused extensive dental damage.

The court is actively reviewing motions to set timelines for pretrial activity and determine the parameters for early discovery phases.

If you or a loved one took Suboxone and experienced severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact Keith Law Group for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to connect with a Suboxone lawyer.

July 31, 2025: Suboxone Tooth Decay Lawsuits Accelerate as MDL Surpasses 11,000 Cases and Court Streamlines Filing Process

The Suboxone multidistrict litigation (MDL 3092) continues to grow, with more than 11,000 cases now pending in federal court.

Plaintiffs across the country allege that Suboxone sublingual film, manufactured by Indivior, caused serious dental injuries—including tooth loss, decay, and erosion—due to its acidic formulation.

U.S. District Judge Philip Calabrese, who presides over the MDL in Ohio, recently authorized a “block filing mechanism” that permits up to 100 claimants to be included in a single complaint.

This order is expected to make it easier for injured individuals to pursue justice by simplifying and accelerating filings.

Despite years on the market, Suboxone did not carry a dental injury warning until June 2022. Plaintiffs argue the manufacturer concealed risks from both consumers and healthcare providers.

Scientific data, including a 2022 JAMA report, further supports claims that sublingual buprenorphine is associated with elevated dental harm.

While the court narrowed some design defect arguments in an earlier ruling, key failure-to-warn claims remain active.

The first bellwether trials are slated for late 2025 or early 2026, serving as a critical milestone in evaluating the litigation’s direction and potential for settlement.

July 21, 2025: Suboxone Tooth Decay Lawsuits Accelerate as MDL Surpasses 11,000 Cases and Court Streamlines Filing Process

During the most recent status conference in the Suboxone multidistrict litigation (MDL), U.S. District Judge Philip Calabrese approved a series of important procedural agreements that will guide the next phase of discovery.

These include finalizing redactions for prior deposition transcripts and standardizing medical release forms for new plaintiffs.

The parties also agreed to begin tracking all claims filed after October 7, 2024, as the litigation continues to grow.

Discussions are underway regarding the logistics of collecting documents from key individuals central to the case.

Judge Calabrese ruled on two disputed issues concerning the language used in Rule 30(b)(6) deposition notices and ordered counsel to continue working together on resolving another pending document dispute.

The court set upcoming deadlines for submitting a plan to collect non-custodial documents and for exchanging fact sheets that outline each side’s core claims and defenses.

An in-person hearing has been scheduled for September 9, signaling continued momentum as the MDL progresses through discovery.

This latest activity highlights the court’s commitment to efficient case management as thousands of Suboxone dental injury claims move forward.

July 15, 2025: Judge Reappoints Leadership in Suboxone Tooth Decay MDL as Bellwether Trials Move Forward

On July 14, 2025, U.S. District Judge Philip Calabrese reappointed nearly 30 attorneys to continue in leadership roles for the federal Suboxone tooth decay litigation, which is centralized in the Northern District of Ohio.

This team will remain responsible for overseeing pretrial coordination, managing discovery, and guiding the development of early bellwether trials in MDL No. 3092.

The reappointment was issued ahead of a July 15 case management conference, where the court is expected to review the progress of bellwether case selection.

With over 11,000 lawsuits currently consolidated, plaintiffs allege that Suboxone caused significant dental injuries—including tooth decay and loss—and that the drug’s manufacturer failed to provide adequate warnings.

Earlier this year, the court created a records pool of 500 cases.

From that pool, 100 lawsuits were selected for more extensive discovery, which will later be narrowed to 15 cases.

Five of those will ultimately be chosen for the first bellwether jury trials.

These initial trials are designed to provide insight into jury responses and could play a critical role in shaping potential settlement discussions.

If no global resolution is reached, individual cases may be returned to their original jurisdictions for trial.

The bellwether process marks a pivotal phase in this fast-growing litigation.

June 2nd, 2025: June 2025 JPML Update

Between May and June, the number of lawsuits in the Suboxone MDL declined slightly, moving from 896 to 892 total filings.

This minor shift may reflect administrative corrections or consolidation, but the core litigation continues to advance.

Plaintiffs claim that long-term use of Suboxone film strips—used in opioid addiction treatment—caused extensive dental harm, including tooth loss and jaw deterioration.

These injuries are being linked to the medication’s buprenorphine content and highly acidic pH.

Lawyers are awaiting key Daubert decisions that will determine if expert testimony on Suboxone’s enamel-damaging properties will be permitted in court.

The next case management hearing is expected to provide further clarity on the bellwether trial schedule.

If you or a loved one took Suboxone and experienced severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact Keith Law Group for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to connect with a Suboxone lawyer.

May 1st, 2025: May 2025 JPML Update

Suboxone lawsuits continue to push ahead, despite no new additions to the MDL in the last month.

The total case count remains at 896, reflecting a brief pause in filings but not in momentum.

Plaintiffs in these cases allege that extended use of Suboxone led to serious dental injuries, including tooth decay, crumbling teeth, and the need for extractions.

At the core of the litigation are claims that the drug’s manufacturers failed to provide adequate warnings about the oral health risks associated with Suboxone film.

Keith Law Group continues to monitor developments closely as the litigation progresses, with many victims still stepping forward to explore their legal options.

If you or a loved one took Suboxone and experienced severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact Keith Law Group for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to connect with a Suboxone lawyer.

April 29th, 2025: Suboxone MDL Moves Forward with Record Collection Phase for Bellwether Trials

Progress continues in the Suboxone tooth decay MDL, as the court initiates its first major phase of bellwether trial preparation.

A pool of 500 plaintiffs—100 with formally filed lawsuits and 400 under tolling agreements—has been selected for medical record collection.

These individuals are now required to sign authorizations so that defendants can begin reviewing their dental and treatment histories.

The record collection process will move forward until 85% of the records have been received, which is expected to take approximately six months.

Once that threshold is met, the court and counsel will begin identifying specific cases for the first bellwether trials.

These early trials will play a key role in assessing claims that Suboxone film caused widespread dental damage due to prolonged contact with patients’ teeth and gums.

The findings may significantly influence jury outcomes and potential settlement talks moving forward.

If you or a loved one took Suboxone and experienced severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact Keith Law Group for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to connect with a Suboxone lawyer.

April 7th, 2025: Suboxone Filing Deadline Approaches for Tooth Decay Claims

As the June 2025 deadline for filing Suboxone lawsuits nears in states with a three-year statute of limitations, thousands of people suffering from tooth decay and other dental problems due to Suboxone use are expected to pursue legal action.

Suboxone, used for opioid addiction treatment, has been linked to significant dental damage, including tooth decay and loss, particularly among users of the sublingual film version.

In June 2022, the manufacturer, Indivior, updated the warning label for the drug, recognizing the risks of tooth decay and dental erosion for the first time.

This label change sparked a wave of lawsuits, leading to the consolidation of more than 10,000 claims into a multidistrict litigation (MDL).

Many individuals were unaware of the link between their dental issues and Suboxone until the label was updated, causing confusion about when the statute of limitations begins.

Consequently, people in states with a three-year statute of limitations are now racing against time to file their claims by June 2025.

Failure to meet this deadline could prevent them from obtaining compensation for their injuries.

If you or a loved one took Suboxone and experienced severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact Keith Law Group for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to connect with a Suboxone lawyer.

April 1st, 2025:  April 2025 JPML Update

The number of Suboxone Tooth Decay Lawsuits remained unchanged between March and April 2025, holding steady at 896 total cases.

This stability follows a period of rapid growth in filings earlier in the year.

The lawsuits allege that long-term use of Suboxone, a medication commonly prescribed to treat opioid addiction, caused significant dental problems—such as tooth decay, enamel erosion, and oral infections.

Plaintiffs claim that manufacturers failed to adequately warn users about these risks, despite growing reports of oral health complications.

As the litigation progresses, focus remains on discovery and bellwether trial planning, which could shape the direction of future Suboxone settlements.

If you or a loved one took Suboxone and experienced severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact Keith Law Group for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to connect with a Suboxone lawyer.

March 17th, 2025: Judge Allows Bulk Filing of Suboxone Tooth Decay Lawsuits as New Wave of Claims Expected

Suboxone litigation is moving forward with a major update: plaintiffs can now file in bulk.

The judge overseeing the Suboxone Tooth Decay MDL has approved a rule allowing up to 100 plaintiffs to be grouped in a single filing, helping reduce costs and improve efficiency as case numbers rise.

With more than 10,000 lawsuits pending and the three-year anniversary of the FDA’s 2022 warning approaching, the statute of limitations may soon limit claims in some states.

Suboxone manufacturers argue that claims not filed before June 2025 could be barred.

The court has also implemented a 500-plaintiff Record Collection Pool and is planning bellwether trials to estimate future jury outcomes.

While these early trials won’t decide all cases, they could play a key role in shaping future Suboxone settlements.

If you or a loved one took Suboxone and experienced severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact Keith Law Group for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to connect with a Suboxone lawyer.

March 3rd, 2025: Suboxone Tooth Decay MDL Shows No Change

As of March 2025, the Suboxone tooth decay litigation maintained a total of 896 new filings, showing no change from the 896 cases in February 2025.

February, however, had experienced a decline of 142 cases from the month before.

Our legal team is closely following updates in the Suboxone Lawsuit and is committed to helping those affected pursue compensation for the damages caused by Suboxone-related tooth decay.

If you or a loved one took Suboxone and experienced severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact Keith Law Group for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to connect with a Suboxone lawyer.

February 20th, 2025: Federal Judge Orders Medical Providers to Submit Suboxone Records

A federal judge handling the Suboxone tooth decay lawsuits has ruled that pharmacies and medical providers must produce the requested medical records within 30 days.

This ruling seeks to avoid delays in the growing litigation. More than 11,000 lawsuits claim that Suboxone film caused significant tooth decay.

Plaintiffs’ attorneys are working to collect dental records and prescription histories in preparation for early bellwether trials.

However, obstacles in obtaining these records have slowed the process. Some providers have imposed inconsistent authorization requirements, complicating plaintiffs’ access to vital documentation.

Judge Philip Calabrese, who is overseeing the multidistrict litigation (MDL) in the Northern District of Ohio, has directed that providers accept both electronic and ink-signed authorizations, barring any additional requirements like photo ID requests that could delay the process.

The next status conference is scheduled for March 11, and more Suboxone lawsuits are expected before the FDA’s 2022 label update regarding tooth decay risks.

If you or a loved one took Suboxone and experienced severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact Keith Law Group for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to connect with a Suboxone lawyer.

February 5th, 2025: Suboxone Film MDL Moves Forward with Bellwether Protocol

MDL 3092, the Suboxone (buprenorphine/naloxone) Film Products Liability Litigation, is progressing with its bellwether protocol for trial cases.

This MDL consolidates claims against Suboxone Film manufacturers, alleging the product caused dental injuries.

Steps are being taken to organize discovery, including forming the Bellwether Pool of cases.

The Plaintiffs’ Liaison Counsel (PLC) has proposed expanding the discovery pool to include 50 plaintiffs, with the potential for up to 250 depositions before bellwether cases are selected.

Negotiations are also underway between the PLC and defendants on the timeline for producing required documents and custodial files.

A proposed case management order details the selection process for bellwether cases.

100 cases will be chosen at random, and plaintiffs must provide documentation, such as proof of Suboxone use and dental injuries.

The bellwether process will follow a structured schedule, with trial preparations expected to begin in 2026.

If you or a loved one took Suboxone and experienced severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact Keith Law Group for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to connect with a Suboxone lawyer.

February 3rd, 2025: Suboxone Tooth Decay MDL grows by 142

As of February 2025, the number of Suboxone Tooth Decay Lawsuits in the MDL reached 896, marking an increase of 142 cases from the 754 lawsuits reported in January 2025.

Plaintiffs argue that the medication, which is commonly prescribed for opioid addiction treatment, has caused extensive tooth decay and serious oral health complications.

The notable surge in filings suggests that more people are coming forward with similar experiences and seeking compensation for the harm caused.

With growing awareness of Suboxone’s potential dental side effects, the litigation continues to grow as those affected pursue justice for their oral health damage.

If you or a loved one took Suboxone and experienced severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact Keith Law Group for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to connect with a Suboxone lawyer.

January 20th, 2025: Suboxone MDL Faces Surge in Filings as June 2025 Statute of Limitations Deadline Nears

The Suboxone multidistrict litigation (MDL) is bracing for a sharp rise in filings as a potential statute of limitations cutoff in June 2025 approaches.

Those in states with a three-year limitations period may face their final opportunity to bring claims against the makers of Suboxone, an opioid addiction treatment tied to severe dental issues like tooth decay and erosion.

U.S. District Judge Philip Calabrese, managing the MDL in the Northern District of Ohio, has noted the court’s readiness for an influx of new lawsuits.

With no tolling agreements in place, plaintiffs will need to file individually before the deadline.

Formed in 2024, the MDL combines more than 10,000 claims accusing the manufacturer of failing to warn about Suboxone’s dental risks.

The warnings were not issued until June 2022, following an FDA mandate, leading to allegations that timely disclosure could have mitigated harm.

In 2024, a bundled complaint included over 9,500 plaintiffs from states with shorter limitation periods.

The wave of expected filings will add pressure to the court, which still has 8,600 pending cases from the initial bundle.

Claimants are encouraged to file promptly to meet the deadline and seek compensation for Suboxone-related injuries.

If you or a loved one took Suboxone and experienced severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact Keith Law Group for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to connect with a Suboxone lawyer.

January 15, 2025

Teva Pharmaceuticals is taking active steps to dismiss cases before settlement discussions progress.

In a recent action, Teva responded to a Show Cause Order from the Northern District of Georgia, identifying deficiencies in a plaintiff’s documentation.

The company issued a Deficiency Letter, emphasizing unmet procedural requirements.

This move highlights Teva’s broader strategy of insisting on strict procedural compliance, which may reduce the number of ongoing claims.

At the same time, progress toward a global settlement is ongoing.

Sixteen months ago, retired judge M. Gino Brogdon Sr. was appointed to oversee the settlement talks as part of the multidistrict litigation (MDL).

Mediators play an important role in resolving complex MDLs, and Brogdon’s involvement is expected to increase as 2025 unfolds.

Although hopes remain high for a global settlement before trial, the timeline for resolution is still unclear.

Both plaintiffs and defendants are at crucial junctures, where careful procedural actions and proactive negotiations will be critical in determining the outcome of this significant litigation.

If you or a loved one took Suboxone and experienced severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact Keith Law Group for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to connect with a Suboxone lawyer.

January 7, 2025

Significant progress is being made in the Suboxone MDL after the judge ruled on the Motion to Dismiss, with the decision being approximately 80% favorable to the Plaintiffs.

The court allowed essential claims, such as failure to warn and design defects, to continue against the manufacturer. However, the design defect claim for cases filed after 2010 was dismissed.

Plaintiffs will proceed with failure to warn claims, extending to 2022, but these claims are now limited to the defendant Indivior, responsible for the drug’s labeling.

Despite some unfavorable outcomes for Indivior, this ruling represents a major win for plaintiffs in the Suboxone Tooth Decay Lawsuits.

As the case shifts into a new phase with a focus on discovery, expert testimony, and bellwether trials, the next Case Management Conference on January 14, 2025, will provide important insights into the litigation’s trajectory for the remainder of the year.

If you or a loved one took Suboxone and experienced severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact Keith Law Group for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to connect with a Suboxone lawyer.

January 2, 2025

The Suboxone (Buprenorphine/Naloxone) Film Products Liability Litigation has seen its pending lawsuits grow from 716 in December 2024 to 754 in January 2025, with 38 new cases filed in the past month.

Litigation centers on Suboxone, a medication commonly prescribed for opioid addiction, after findings linked its sublingual form to severe tooth decay.

The recent surge in filings reflects an increasing number of individuals pursuing legal claims against the drug’s manufacturers, seeking accountability and compensation for its adverse effects.

If you or a loved one took Suboxone and experienced severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact Keith Law Group for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to connect with a Suboxone lawyer.

December 19, 2024

This week, the Suboxone mass tort litigation entered a pivotal phase with oral arguments presented for the Defendants’ Motion to Dismiss.

The motion, filed in June 2024, centers around a preemption defense, which is frequently raised in mass tort cases involving FDA-approved products.

In cases involving prescription drugs, manufacturers may argue that they cannot be held liable under state laws because their products were approved by the federal government, such as the FDA (Food and Drug Administration).

The Defendants claim that the FDA’s approval of Suboxone, along with the lack of verified adverse event reports, limited their ability to alter the label to warn about the potential risk of tooth decay.

On the other hand, the Plaintiffs argue that FDA approval does not relieve manufacturers of their responsibility to monitor, report, and disclose risks, including tooth decay, potentially linked to Suboxone use.

Judge Calabrese is expected to issue a ruling on the Motion to Dismiss before the upcoming Case Management Conference, set for January 14, 2025. 

Should the Plaintiffs prevail, the litigation could move forward toward discovery and possible trials, advancing claims for compensation related to Suboxone-associated dental injuries.

If you or a loved one took Suboxone and experienced severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact Keith Law Group for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to connect with a Suboxone lawyer.

December 17, 2024

A federal judge presiding over more than 11,000 Suboxone tooth decay lawsuits heard arguments on December 16 regarding Indivior’s motion to dismiss the claims.

The motion focuses on federal preemption, with Indivior claiming that federal law barred earlier updates to Suboxone’s warning labels, thereby invalidating state-based failure-to-warn lawsuits.

Plaintiffs assert that Indivior failed to warn about severe dental issues, including tooth decay and enamel erosion, despite numerous reports of these problems before a June 2022 label update.

They argue that Indivior was responsible for alerting users and healthcare providers to the risks and claim that safer methods of administering the medication’s active ingredients were available.

These lawsuits have been centralized in a multidistrict litigation (MDL) under U.S. District Judge Philip Calabrese in the Northern District of Ohio.

Although the judge did not decide on the motion to dismiss, additional case management conferences are scheduled for April, May, and June 2025 to keep the proceedings on track.

Should the motion to dismiss be denied, the Court is expected to select bellwether cases for early trials.

These trials, while not binding on other claims, could play a pivotal role in shaping future settlement discussions, as their outcomes will serve as benchmarks for resolving the broader litigation.

If you or a loved one took Suboxone and experienced severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact Keith Law Group for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to connect with a Suboxone lawyer.

December 4, 2024

More than 11,000 Suboxone tooth decay lawsuits face a critical juncture as oral arguments on a motion to dismiss are scheduled for December 16.

Indivior, the drug’s manufacturer, argues that it was unable to update Suboxone’s warning labels before June 2022 due to federal law preemption.

Plaintiffs in these lawsuits claim that Suboxone, a sublingual film prescribed for opioid addiction treatment, causes significant dental issues, including enamel degradation, cavities, oral infections, and tooth loss.

They allege that Indivior failed to warn users despite knowing—or having reason to know—about these risks and continued marketing the drug without appropriate preventative guidance.

The lawsuits have been centralized in multidistrict litigation (MDL) under U.S. District Judge Philip Calabrese in the Northern District of Ohio.

Following a November status conference, Judge Calabrese will address the motion during oral arguments on December 16.

The court has requested a joint report from the parties by December 12 to outline any additional matters requiring consideration.

If the motion to dismiss is denied, the MDL will proceed with selecting bellwether cases, which could provide insights into potential outcomes for the broader litigation.

While the bellwether trials will not be binding for other claims, they are expected to influence settlement discussions and shape Indivior’s strategy in resolving the lawsuits.

If you or a loved one took Suboxone and experienced severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact Keith Law Group for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to connect with a Suboxone lawyer.

December 2, 2024

In November, the Judicial Panel on Multidistrict Litigation (JPML) recorded 678 case filings for the Suboxone Tooth Decay lawsuit.

This number increased to 716 in December, reflecting a growth of 38 cases.

The lawsuit alleges that Suboxone, used for opioid addiction treatment, has caused severe dental issues, including tooth decay and loss, due to insufficient warnings from the manufacturer regarding these risks.

The increase in filings may indicate heightened awareness among both patients and healthcare providers of the association between Suboxone use and dental complications.

As the litigation develops, additional plaintiffs continue to come forward, seeking justice for the harm allegedly caused by the medication.

If you or a loved one took Suboxone and experienced severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact Keith Law Group for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to connect with a Suboxone lawyer.

November 6, 2024

Suboxone Tooth Decay Litigation Update: Judge Orders Comprehensive Census for Trial PreparationThe U.S. District Judge overseeing the Suboxone tooth decay lawsuits has mandated a complete census of all current claims.

This census will give an overview of the cases and pinpoint representative claims that may proceed to early bellwether trials, helping the parties assess how juries might respond.

Indivior faces over 11,000 lawsuits alleging that Suboxone’s sublingual film led to severe dental issues, such as tooth decay and enamel erosion, which plaintiffs claim were not sufficiently disclosed.

Despite Suboxone’s long presence on the market, warnings about dental risks were not added until June 2022, which plaintiffs contend contributed to preventable injuries.

These lawsuits have been consolidated in a multidistrict litigation (MDL) overseen by U.S. District Judge Philip Calabrese, who is coordinating discovery and preparing for bellwether trials to offer insights into likely jury responses to shared evidence.

After an October 2024 conference, Judge Calabrese issued a case management order specifying the census protocols.

The census will encompass both individual lawsuits and bundled Schedule A cases submitted earlier this year, excluding cases filed after October 7, 2024.

This census and related proceedings are essential steps in advancing the litigation and assessing fair compensation for Suboxone users affected by dental damage.

If you or a loved one took Suboxone and experienced severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact Keith Law Group for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to connect with a Suboxone lawyer.

November 1, 2024

The Suboxone Tooth Decay Lawsuit involves claims that the opioid addiction treatment drug Suboxone has caused serious dental issues, including advanced tooth decay, erosion, and even tooth loss.

Plaintiffs argue that the manufacturer, Indivior, did not sufficiently warn users of the significant risk of dental damage associated with Suboxone use.

In October, there were 674 cases filed regarding Suboxone-related tooth decay claims. By November, this number had risen slightly to 678, with 4 additional cases.

This gradual increase indicates that awareness of potential dental complications from long-term Suboxone use continues to grow.

Suboxone’s effects on dental health can result in painful and costly dental treatments, impacting the quality of life for individuals using the medication for opioid addiction treatment.

If you or a loved one took Suboxone and experienced severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact Keith Law Group for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to connect with a Suboxone lawyer.

The Suboxone Tooth Decay Lawsuit highlights claims that the drug, prescribed for opioid addiction and opioid use disorder (OUD), causes severe dental damage, including tooth decay, tooth loss, and other oral health issues.

Plaintiffs contend that Suboxone’s manufacturers failed to adequately warn about the drug’s potential to cause serious dental harm.

In September and October, the Judicial Panel on Multidistrict Litigation (JPML) recorded 674 active Suboxone tooth decay lawsuits.

Suboxone users have reported rapid tooth decay and tooth loss, leading to costly dental procedures such as root canals, dentures, or implants.

If you or a loved one took Suboxone and experienced severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact Keith Law Group for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to connect with a Suboxone lawyer.

The Suboxone Lawsuit is ongoing. 

An Ohio federal judge recently dismissed Indivior PLC and two Reckitt Benckiser entities from the Suboxone MDL, which alleges that Suboxone, an opioid addiction treatment, caused dental decay.

U.S. District Judge J. Philip Calabrese issued the dismissal after the parties involved reached an agreement.

In the case filed by plaintiff Ryan Bennett, the dismissal was with prejudice, meaning it cannot be refiled.

However, for other claims in the MDL, the dismissal was without prejudice, allowing those cases to potentially be brought again.

The litigation centers on allegations that the companies failed to warn consumers about Suboxone’s dissolvable film, which has acidic properties that could damage teeth.

While Indivior and Reckitt Benckiser have been dismissed, the litigation continues against other defendants, including Aquestive Therapeutics Inc.

The MDL, consolidated in February 2024, includes claims from multiple states and follows Indivior’s earlier settlement of antitrust claims over Suboxone in a separate case.

If you or a loved one took Suboxone and experienced severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact Keith Law Group for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to connect with a Suboxone lawyer.

The Suboxone Tooth Decay Lawsuit, involving allegations that Suboxone use has caused serious dental issues, has seen a minor increase in filings.

In August 2024, there were 673 active cases, with the number rising slightly to 674 by September 2024.

Plaintiffs argue that despite following good dental practices, Suboxone users have experienced severe tooth decay, and they claim the manufacturer failed to adequately warn of these potential risks.

If you or a loved one took Suboxone and subsequently suffered severe tooth decay, you may be eligible to take action and file a Suboxone Lawsuit. 

Contact TruLaw for a free consultation. 

Use the chatbot on this page to find out if you qualify to file a Suboxone Lawsuit and to get in touch with a licensed Suboxone lawyer.

The Suboxone Lawsuit involves claims against the drug’s manufacturer regarding a heightened risk of severe tooth decay and other dental injuries.

In July, there were 677 filings in the Suboxone lawsuit, which slightly decreased to 673 by August.

Suboxone, a medication used to treat opioid addiction, has been linked with severe tooth decay, including cavities, tooth loss, and other severe dental problems.

Many individuals have filed lawsuits against Indivior, claiming that the company failed to adequately warn about these dental risks, leading to significant health complications and financial issues for dental treatments.

If you or a loved one took Suboxone and subsequently suffered severe tooth decay, you may be eligible to take action and file a Suboxone Lawsuit. 

Contact Keith Law Group for a free consultation. 

Use the chatbot on this page to find out if you qualify to file a Suboxone Lawsuit and to get in touch with a licensed Suboxone lawyer.

July 29, 2024

August 16 & 27, 2024: Key Submission Dates

Key dates for the Suboxone Tooth Decay Lawsuit are fast approaching. 

Suboxone Lawsuits are advancing with submission dates in August 2024 and a potential settlement timeline extending into mid-2025.

The litigation is continuing to grow, and lawyers are still accepting new Suboxone claims.

In June 2024, there were 258 Suboxone Lawsuit filings reported by the JPML.

By July 2024, the number of Suboxone Lawsuits had increased to 677.

Key Submission Dates:

• Claim information and party proposals due on August 16 and 27, 2024. These documents are vital for progressing the litigation and may significantly impact the direction of the case.

Settlement Timeline:

• Settlement discussions are expected to extend into mid-2025.
• The earliest potential settlement by June 2025, pending resolution of ongoing issues within the litigation.

Tolling Agreement:

• Progress report due on August 1, 2024.
• The tolling agreement pauses the statute of limitations, allowing time for comprehensive case preparation.

If you or a loved one took Suboxone and subsequently suffered severe tooth decay, you may be eligible to take action and file a Suboxone Lawsuit. 

Contact Keith Law Group for a free consultation. 

Use the chatbot on this page to find out if you qualify to file a Suboxone Lawsuit and to get in touch with a licensed Suboxone lawyer.

The Suboxone Lawsuit is ongoing.

The number of Suboxone lawsuits has increased as more patients come forward to report severe tooth decay and other dental problems associated with the medication, seeking legal support from Suboxone Lawyers.

Suboxone Tooth Decay Lawsuits involve claims of dental injuries resulting from the use of the drug, a medication used for opioid addiction treatment.

The core arguments in the Suboxone Tooth Decay Lawsuits revolve around:

• Failure to Warn: Plaintiffs argue that the manufacturers did not provide adequate warnings about the risk of severe tooth decay associated with Suboxone.

• Negligent Design: Allegations include that the design of Suboxone contributes to an increased risk of dental problems, including tooth decay.

• Lack of Adequate Instructions: Many lawsuits claim that the manufacturers failed to provide proper instructions on how to minimize dental risks while using Suboxone.

In response to the increasing litigation, healthcare professionals recommend the following precautions for those using Suboxone:

• Maintain Oral Hygiene: Follow a strict oral hygiene routine, including brushing and flossing regularly.

• Regular Dental Check-Ups: Schedule frequent dental check-ups to monitor and address any early signs of tooth decay.

• Discuss with Your Doctor: Talk to your healthcare provider about the potential dental risks and ways to mitigate them while using Suboxone.

If you or a loved one has suffered from dental issues due to Suboxone, contact Keith Law Group for a free consultation.

The Suboxone lawsuit is ongoing.

The lawsuit involves claims that the opioid addiction treatment drug Suboxone has caused severe dental issues, including tooth decay, tooth loss, and other dental problems.

This lawsuit seeks to hold the manufacturer accountable for these adverse effects.

In June, there were 258 Suboxone lawsuit filings.

By July, this number increased to 677.

Suboxone can cause significant dental problems, leading to tooth decay and tooth loss.

These issues have prompted more individuals to join the Suboxone lawsuit.

If you or a loved one has been negatively affected by Suboxone, call today for a free consultation. 

You can also use the chatbot on this page for an instant case evaluation

In a recent development, over 9,600 people have added their claims to a collective lawsuit against the manufacturers of Suboxone.

These claims were filed just ahead of a potential cutoff date that could have impacted claim eligibility across several states.

Suboxone, a drug prescribed for opioid addiction treatment, has been linked to serious dental issues such as tooth decay and irreversible damage.

The medication, which contains buprenorphine and naloxone, is commonly used to mitigate opioid withdrawal symptoms.

Initially approved in tablet form in 2002, a sublingual film version was introduced in 2012.

The plaintiffs in the lawsuit argue that this film form was introduced to delay the entry of generic alternatives and failed to provide sufficient warnings about the risks to dental health.

The FDA mandated a warning label for tooth decay on June 17, 2022, following numerous reports of tooth loss.

With the second anniversary of the FDA’s label update approaching, approximately 500 Suboxone lawsuits are currently active in federal courts.

These cases are being managed by U.S. District Judge Philip Calabrese in the Northern District of Ohio, as part of a multidistrict litigation (MDL) that was established in February 2024.

This MDL is designed to streamline discovery and pretrial processes.

Judge Calabrese is anticipated to introduce a bellwether process soon, choosing representative cases for early trials to set precedents for future settlement negotiations.

If you or someone else has suffered from serious tooth decay as a result of using Suboxone, you may be eligible to participate in the Suboxone Lawsuit. 

Contact us for a free consultation, or utilize the chatbot on this page to quickly check your eligibility for the Suboxone Tooth Decay Lawsuit.

The Suboxone Tooth Decay Lawsuit is ongoing. 

U.S. District Judge Philip Calabrese, overseeing the consolidated Suboxone dental decay lawsuits, has formed a Leadership Development Committee (LDC) to enhance case management and legal representation in the Multidistrict Litigation (MDL).

This committee plays a critical role in addressing the broad claims that Suboxone film causes severe dental decay, a side effect not previously disclosed by the drug’s manufacturer.

Suboxone, a drug used for opioid addiction treatment, was introduced in a sublingual film format in 2012.

This formulation of the drug has been linked to severe dental health issues, including enamel erosion, tooth decay, cavities, oral infections, and tooth loss.

After numerous patient complaints, on June 17, 2022, the FDA mandated warnings about the risk of tooth decay to be included on the drug’s labeling.

Plaintiffs argue that earlier warnings could have prevented irreversible dental harm.

Currently, there are approximately 350 product liability lawsuits active in the MDL, and this number is expected to increase as the two-year anniversary of the labeling change approaches—a potential deadline for new claims.

These cases are centralized in the Northern District of Ohio, where they are undergoing coordinated pretrial proceedings under Judge Calabrese.

If you or someone else has suffered from serious tooth decay as a result of using Suboxone, you may be eligible to participate in the Suboxone Lawsuit. 

Contact us for a free consultation, or utilize the chatbot on this page to quickly check your eligibility for the Suboxone Tooth Decay Lawsuit.

The Suboxone Tooth Decay Lawsuit is progressing, and we are open to new clients. The latest data from the Judicial Panel on Multidistrict Litigation (JPML) shows that 258 lawsuits have now been consolidated into the Suboxone (Buprenorphine/Naloxone) Film Products Liability Litigation.

These cases assert that Suboxone, especially in its sublingual film or tablet forms, greatly increases the risk of severe tooth decay due to extended contact of the teeth with decay-inducing substances.

This litigation unifies these allegations in a single federal court, addressing the serious dental problems purportedly linked to Suboxone use.

If you or someone else has suffered from serious tooth decay as a result of using Suboxone, you may be eligible to participate in the Suboxone Lawsuit. 

Contact us for a free consultation, or utilize the chatbot on this page to quickly check your eligibility for the Suboxone Tooth Decay Lawsuit.

The Suboxone Tooth Decay Lawsuit is ongoing. 

In the Suboxone lawsuit, plaintiffs are advocating for a tolling agreement to temporarily suspend the statute of limitations, enabling the submission of additional claims for dental injuries allegedly caused by Suboxone.

Since November 2023, the argument has centered on the necessity of such an agreement to effectively manage the litigation.

As of May 2024, there are nearly 500 cases pending in the Suboxone lawsuit.

PLaintiffs caution that without a tolling agreement, the court may face a flood of potential unapproved  claims, which could complicate proceedings and detract from the MDL’s objective of streamlining the process.

Defendants in the Suboxone Tooth Decay lawsuit have consistently opposed the tolling agreement.

This opposition is perceived by plaintiffs as a tactic to increase the litigation burden, potentially deterring the filing of weaker claims and complicating the management of the MDL.

The controversy extends to the Suboxone warning label, updated on June 17, 2022, under FDA guidance to include risks of dental decay and tooth erosion.

The plaintiffs have proposed that the court obligate defendants to respond to each complaint, an effort to pressure defendants into agreeing to the tolling agreement and thus manage their caseload more efficiently, amid concerns of filing claims that may later be dismissed as meritless.

Decisions by the court in the upcoming months could significantly shape the trajectory of the Suboxone Tooth Decay litigation, influencing the strategies of both parties involved in the lawsuit.

The Suboxone Lawsuit remains active.

As per the latest filings with the Judicial Panel on Multidistrict Litigation (JPML), there are currently 205 cases consolidated in the Suboxone (Buprenorphine/Naloxone) Film Products Liability Litigation.

This marks a substantial increase, with 161 new cases joining the litigation just in the past month, up from only 44 cases as of April 1st.

The claims in these lawsuits assert that the formulation of Suboxone, especially in its sublingual film or tablet form, results in extended exposure of the teeth to decay-promoting substances.

The Suboxone (Buprenorphine/Naloxone) Film Products Liability Litigation consolidates various lawsuits that attribute severe tooth decay to the use of Suboxone into one federal court.

If you or someone close to you has suffered from severe tooth decay as a result of using Suboxone, you may be eligible to file a Suboxone Lawsuit.

Contact us for a free consultation.

You can also determine if you qualify for the Suboxone Tooth Decay Lawsuit instantly by using the chatbot on this page.

As of April 1st, the total number of Suboxone Lawsuits has decreased to 44, down from 51 on March 1st.

These lawsuits have been filed against the manufacturers of Suboxone by individuals who used the drug for opioid addiction treatment and subsequently experienced severe tooth decay and other dental injuries.

In response to these claims, the U.S. Food and Drug Administration (FDA) mandated in 2022 that all Suboxone packaging include warning labels addressing the potential risk of dental problems.

This regulatory action followed reports that many users were not adequately informed of the risks associated with dental health prior to using the medication.

If you or a loved one has been affected by Suboxone, call us today for a free consultation. 

Alternatively, you can use the chatbot on this page for an instant Suboxone Tooth Decay lawsuit evaluation.

The United States District Court for the Northern District of Ohio is currently overseeing the Suboxone Tooth Decay Lawsuit, part of Multidistrict Litigation (MDL) No. 3092.

The court has introduced a direct filing system to facilitate the process for plaintiffs alleging dental injuries due to Suboxone, a medication prescribed for opioid addiction treatment.

This system allows for the consolidation of cases, streamlining the litigation process by eliminating the need for case transfers from various jurisdictions to this centralized court.

Suboxone combines buprenorphine, to alleviate withdrawal symptoms, with naloxone, intended to prevent misuse.

However, forms of Suboxone that dissolve in the mouth have been associated with severe dental issues, including tooth decay, cavities, and loss.

The direct filing mechanism not only expedites the legal proceedings but also simplifies representation by attorneys nationwide, without the need for special permissions or additional fees.

Plaintiffs filing lawsuits are encouraged to propose a trial location tied to personal aspects of their case, such as residency, prescription, or use of Suboxone.

While this does not assure a trial in the suggested locale, it aids in the organization and management of cases within the MDL structure.

This initiative by the Northern District of Ohio aims to enhance access and efficiency for individuals seeking compensation for dental damages allegedly linked to Suboxone.

Individuals experiencing dental problems following Suboxone use are encouraged to seek legal counsel.

The legal battle surrounding Suboxone continues to unfold, with our attorneys actively welcoming additional cases.

As of March 19th, there have been 51 cases incorporated into the Multidistrict Litigation (MDL) addressing tooth decay attributed to Suboxone.

MDLs play a crucial role in efficiently managing multiple lawsuits that share commonalities, particularly in sectors like pharmaceuticals, product defects, and intricate legal issues.

The consolidation of Suboxone cases helps simplify the discovery process, facilitating the exchange of evidence, and expediting the proceedings of individual lawsuits.

The establishment of an MDL specific to Suboxone lawsuits marks an important milestone in the management and potential resolution of these cases.

This approach allows for the amalgamation of resources, fostering a more robust legal strategy supported by in-depth expert analysis and detailed investigative efforts.

Individuals who have experienced dental complications from Suboxone use are provided with an avenue to seek legal remedy and possibly engage in a collective endeavor to secure compensation.

The initiation of this MDL reflects a firm commitment to delivering justice for those who have suffered dental injuries as an unintended outcome of their addiction treatment.

Should you or someone close have encountered severe dental issues as a result of taking Suboxone, you might be eligible for legal recourse. 

Utilizing the chatbot on this page enables you to swiftly determine your eligibility to initiate a Suboxone lawsuit and facilitates connection with a lawyer specialized in Suboxone cases.

The Suboxone Litigation is currently underway, and our attorneys are actively taking on new cases. 

The consolidation of the Suboxone Tooth Decay Lawsuit has been designated to the Northern District of Ohio by the Judicial Panel on Multidistrict Litigation (JPML), which has recently integrated eleven cases into this newly established Multi-District Litigation (MDL).

MDLs are procedural frameworks within the United States designed to handle several civil lawsuits that have overlapping legal issues, facts, or defendants efficiently.

This is especially beneficial when numerous lawsuits across different regions share a specific common issue, like tooth decay allegations linked to Suboxone use, allowing for their consolidation in a single federal district court for the preliminary phase of the trial.

The aim of an MDL is to make the litigation process more efficient by centralizing the discovery phase, reducing redundant work, and achieving consistent rulings on crucial legal questions.

The formation of an MDL provides an avenue for individuals suffering from dental issues due to Suboxone to seek collective redress and compensation through mass tort litigation.

Initiating an MDL for Suboxone Tooth Decay is a significant step forward in securing justice for those affected by dental decay or injuries from this opioid addiction treatment. 

If you or a loved one has suffered from severe tooth decay as a result of Suboxone, you may be eligible to take legal action and initiate a lawsuit.

The chatbot on this page is available to help determine if you are eligible to join the Suboxone Lawsuit and to facilitate contact with a seasoned Suboxone lawyer. 

The Suboxone Tooth Decay Lawsuit is ongoing.

Indivior has agreed to a $385 million settlement to address allegations from U.S. drug wholesalers that the company unlawfully blocked generic competitors of its opioid addiction treatment, Suboxone.

This settlement resolves extended legal battles regarding Suboxone, building on earlier settlements: $102.5 million in June to U.S. states and $30 million in August for a class-action lawsuit by health plans.

A trial set for October 30, involving roughly 70 Suboxone buyers, has now been averted through this settlement.

Indivior had exclusive rights to Suboxone in the U.S. from its approval in 2002 until 2009. The lawsuit focused on accusations that Indivior switched to a film version of Suboxone to illegally extend its market monopoly as generic producers were ready to launch cheaper tablet forms.

Furthermore, in 2020, Indivior settled for $600 million to resolve U.S. government claims of misleading marketing practices concerning Suboxone.

The CDC has linked opioids to over 900,000 overdose deaths in the U.S. since 1999.

Indivior’s CEO, Mark Crossley, remarked that the settlement enhances predictability for the company’s stakeholders, noting the settlement does not admit any liability.

The agreement is pending approval by the United States District Court for the Eastern District of Pennsylvania, with the settlement expected to be paid out in the upcoming month.

Should you or someone you know suffer from severe tooth decay as a result of taking Suboxone, you may have a case for legal action.

The chatbot on this page is ready to help determine if you qualify for a Suboxone Lawsuit and to connect you with an experienced Suboxone lawyer.